뉴스
- Genome & Company·LabGenomics Rally in Korea Stock Market[K-BIO PULSE] South Korean pharmaceutical, biotech and healthcare stocks staged a broad-based rally on June 9, as sector-specific catalysts drove sharp gains in select names
- Slow Letter: October 16, 2026. in stock prices will continue to decline until the first half of next year.” Lee Jung-hwan...
- (LEAD) Seoul stocks open sharply lower on lingering concerns over AI, U.S... After opening sharply lower, the benchmark Korea Composite Stock Price Index (KOSPI) tumbled 348.47 points The sharp drop in the index triggered the...
- What to Know About the New Elon Musk Documentary In 2016, Musk oversaw the creation of a promotional video depicting a self-driving Tesla, causing the company’s stock to rise.
- Market Fluctuates, Daehwa Pharm, LabGenomics, and NeoImmuneTech Rise[K-Bio Pulse] On the 7th, amid mixed trading in the South Korean stock market, pharmaceutical and biotech companies
- 중동 불안·美 국채금리 급등에 나스닥 급락…환율 1410원대 후반 상승 압력[외환브리핑] 미국 증시가 일제히 하락한 가운데 원·달러 환율도 1410원 중후반대에서 상승 압력을 받을 전망이다.A trader works on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., August 18, 2026.
- Onconic Surges on Jaqbo’s India Approval[K-Bio Pulse] South Korea’s pharmaceutical and life sciences sectors advanced in tandem on Aug. 6, led by Onconic Therapeutics, Qurient and Voronoi.The pharmaceutical index gained 2.24%, with 97 of 161 stock...
- Kosdaq Bio Rally...Alteogen Soars on European Patent Win [K-bio Pulse] On July 23, the domestic stock market surged as artificial intelligence (AI) investment expectations combined with strong momentum in healthcare and biotechnology stocks.
- BL Pharmtech Hits Daily Limit…Samchundang Pharm Falls[K-bio pulse] Investors in the biopharmaceutical sector continued to show strong interest in BL Pharmtech on July 2 , driving its stock to the daily upper limit.
- Cellid Crashes After-Hours on Phase 3 Failure...Shaperon Dives 25%[K-bio pulse] In the biopharmaceutical sector on Friday, Cellid’s stock surged on expectations for its vaccine clinical trial results, but the shares plunged by the daily limit in after-hours trading followi...
1 페이지
다음 →